JP2007518797A - 膣感染症の処置のための、フルコナゾール−チニダゾールの組み合わせ、ならびに、その組成物、調製プロセスおよび使用 - Google Patents

膣感染症の処置のための、フルコナゾール−チニダゾールの組み合わせ、ならびに、その組成物、調製プロセスおよび使用 Download PDF

Info

Publication number
JP2007518797A
JP2007518797A JP2006550972A JP2006550972A JP2007518797A JP 2007518797 A JP2007518797 A JP 2007518797A JP 2006550972 A JP2006550972 A JP 2006550972A JP 2006550972 A JP2006550972 A JP 2006550972A JP 2007518797 A JP2007518797 A JP 2007518797A
Authority
JP
Japan
Prior art keywords
composition
fluconazole
weight
treatment
tinidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006550972A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007518797A5 (https=
Inventor
ラミレス， ルイサ エルナンデス
パニアフア， アンへリカ アルゾラ
サルガード ロペス， ラウル エー． ガルシア
ロペス フェルナンド ポート，
Original Assignee
アルパリス エセ．アー． デー セ．ウーベ．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アルパリス エセ．アー． デー セ．ウーベ． filed Critical アルパリス エセ．アー． デー セ．ウーベ．
Publication of JP2007518797A publication Critical patent/JP2007518797A/ja
Publication of JP2007518797A5 publication Critical patent/JP2007518797A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2006550972A 2004-01-22 2004-12-17 膣感染症の処置のための、フルコナゾール−チニダゾールの組み合わせ、ならびに、その組成物、調製プロセスおよび使用 Pending JP2007518797A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/762,616 US8309103B2 (en) 2004-01-22 2004-01-22 Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
PCT/MX2004/000094 WO2005070421A1 (es) 2004-01-22 2004-12-17 Asociación de fluconazol-tinidazol para el tratamiento de infecciones vaginales, su composición, proceso de preparación y uso

Publications (2)

Publication Number Publication Date
JP2007518797A true JP2007518797A (ja) 2007-07-12
JP2007518797A5 JP2007518797A5 (https=) 2007-11-22

Family

ID=34794897

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006550972A Pending JP2007518797A (ja) 2004-01-22 2004-12-17 膣感染症の処置のための、フルコナゾール−チニダゾールの組み合わせ、ならびに、その組成物、調製プロセスおよび使用

Country Status (8)

Country Link
US (1) US8309103B2 (https=)
EP (1) EP1712229B1 (https=)
JP (1) JP2007518797A (https=)
BR (1) BRPI0418065A (https=)
CA (1) CA2553646C (https=)
DE (2) DE602004021638D1 (https=)
ES (1) ES2280150T3 (https=)
WO (1) WO2005070421A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008011321A (es) 2008-09-04 2010-03-04 Senosiain S A De C V Lab Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual.
KR20170052626A (ko) * 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸
CA2988082C (en) 2015-06-01 2020-09-29 Symbiomix Therapeutics, Llc Novel nitroimidazole formulations and uses thereof
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000513334A (ja) * 1996-05-17 2000-10-10 エドコ トレーディング アンド リプレゼンテーション カンパニー リミテッド 一種以上の抗膣炎薬および一種以上の局部麻酔剤を含む局部使用用抗膣炎組成物
JP2002512961A (ja) * 1998-04-24 2002-05-08 ラボラトワール イノテラ，ソシエテ アノニム 外陰膣炎および膣症を局所的に治療するための医薬品イミダゾールの併用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2581707B2 (ja) * 1987-10-02 1997-02-12 科研製薬株式会社 抗真菌剤組成物
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
SK282072B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta s obsahom lamotrigínu dispergovateľná vo vode a spôsob jej prípravy
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
DE69831878D1 (de) * 1997-11-24 2006-02-23 Zhongming Zeng Verwendung von dextrin, stärke oder glykogen zur behandlung von bakterieller vaginosis
US20030059471A1 (en) * 1997-12-15 2003-03-27 Compton Bruce Jon Oral delivery formulation
ATE527360T1 (de) * 1998-12-08 2011-10-15 Glaxosmithkline Biolog Sa Neue verbindungen abgeleitet von neisseria meningitidis
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
WO2001095723A1 (en) * 2000-06-15 2001-12-20 Ssl International Plc Parasiticidal composition
US20030064103A1 (en) * 2001-05-01 2003-04-03 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
US20030017207A1 (en) * 2001-05-01 2003-01-23 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
US20030130225A1 (en) * 2001-10-16 2003-07-10 Nawaz Ahmad Novel methods of treating local fungal and bacterial infections
MXPA02007641A (es) 2002-08-08 2004-04-02 Alparis Sa De Cv Uso de farmaceutico de la combinacion de fluconazol-tinidazol y su composicion para la administracion oral.
US20040033968A1 (en) * 2002-08-16 2004-02-19 Lin Shun Y. Optimal volume of intra-vaginal semisolid dosage forms for treating vaginal infections

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000513334A (ja) * 1996-05-17 2000-10-10 エドコ トレーディング アンド リプレゼンテーション カンパニー リミテッド 一種以上の抗膣炎薬および一種以上の局部麻酔剤を含む局部使用用抗膣炎組成物
JP2002512961A (ja) * 1998-04-24 2002-05-08 ラボラトワール イノテラ，ソシエテ アノニム 外陰膣炎および膣症を局所的に治療するための医薬品イミダゾールの併用

Also Published As

Publication number Publication date
US8309103B2 (en) 2012-11-13
US20050165077A1 (en) 2005-07-28
BRPI0418065A (pt) 2007-04-17
ES2280150T1 (es) 2007-09-16
EP1712229A1 (en) 2006-10-18
WO2005070421A1 (es) 2005-08-04
DE04808700T1 (de) 2007-08-09
ES2280150T3 (es) 2009-11-18
CA2553646C (en) 2012-01-31
EP1712229B1 (en) 2009-06-17
CA2553646A1 (en) 2005-08-04
DE602004021638D1 (de) 2009-07-30

Similar Documents

Publication Publication Date Title
US5741525A (en) Vaginal pharmaceutical hydrogen peroxide composition
US20030017207A1 (en) Compositions and methods for treating vulvovaginitis and vaginosis
AU777508B2 (en) Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
ES2734280T3 (es) Composición farmacéutica para su uso en el tratamiento de infecciones de transmisión sexual
JP2007518797A (ja) 膣感染症の処置のための、フルコナゾール−チニダゾールの組み合わせ、ならびに、その組成物、調製プロセスおよび使用
Ekgren et al. Comparison of tinidazole given as a single dose and on 2 consecutive days for the treatment of nonspecific bacterial vaginosis
US20040033968A1 (en) Optimal volume of intra-vaginal semisolid dosage forms for treating vaginal infections
CN112770765B (zh) 用于预防和/或治疗泌尿生殖器粘膜的组合物
US20060264857A1 (en) Absorbent articles with buffer
US20110003000A1 (en) Transvaginal Delivery of Drugs
MXPA06008279A (en) Fluconazole-tinidazole combination for the treatment of vaginal infections, composition thereof and preparation and use of same
RU2320319C1 (ru) Суппозитории вагинальные
KR102784739B1 (ko) 질 세정용 조성물
JP2000119186A (ja) スクラルファート含有局所投与用医薬組成物
Brown Abnormal vaginal discharge: accurate differentiation
Topete et al. Assessment of efficacy of ketoconazole/clindamycin vs metronidazole/nistatine in candidiasic vaginitis and bacterial vaginosis
KR20250162796A (ko) 보호용 생체반응성 중합체 씰
HK40091553A (zh) 阴道凝胶
HK40091553B (zh) 阴道凝胶
Seid Fungal infections
Mendling Therapy
MXPA00007095A (en) Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071002

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071002

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110224

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110523

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110527

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110530

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120202